Reportedly, high expression of METTL3 is associated with poor prognosis of gastric cancer patients; METTL3 overexpression expedites epithelial–mesenchymal transition process and enhances the migrative and invasive abilities of gastric cancer cells [31]. This evidence concerns the gene METTL3 and gastric cancer.